# Cancer Vaccine Targeting Brachyury Protein in Tumors

> **NCT01519817** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 34 (actual)

## Conditions studied

- Neoplasms
- Malignant Solid Tumors
- Colon Neoplasms
- Adenocarcinoma

## Interventions

- **BIOLOGICAL:** GI-6301 (Yeast Brachyury Vaccine)

## Key facts

- **NCT ID:** NCT01519817
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01-05
- **Primary completion:** 2016-03-03
- **Final completion:** 2016-09-01
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2018-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01519817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01519817, "Cancer Vaccine Targeting Brachyury Protein in Tumors". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01519817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*